NeoSurg Technologies, Inc. Receives U.S. Patent

Share Article

Revolutionary New Tip Geometry for its T2000 Reusable Trocar Access System.

NeoSurg Technologies, Inc., a leading developer of minimally invasive access products for laparoscopic surgery, is pleased to announce today that it has been granted a patent relating to its bladeless tip technology. The patent, U.S. No. 6,835,201, titled "Trocar" covers a bladeless tip geometry for the T2000 Reusable Trocar System.

"This unique tip geometry provides for a dorsal element to our existing bladeless tip. We feel this dorsal element will provide additional lateral stability without increasing the penetration force substantially,” said Pete O’Heeron, President/CEO of NeoSurg Technologies, Inc. “This patent will provide the market with a unique geometry and advance our efforts to bring advanced technology to the minimally invasive access market while recognizing the need to reduce cost for each procedure.”

NeoSurg owns patents and has numerous pending patent applications for the minimally invasive access market—showing a strong patent position and commitment to developing clinically sophisticated and cost effective solutions. The objective of the patents is to broaden the intellectual property protection worldwide for the T2000 Technology. Currently, NeoSurg Technology is protected by over 13 patents and patent applications worldwide.

About the T2000 System

The T2000 System consists of a Reusable Trocar constructed of titanium and hard anodized aluminum for durability and reliability. The access tip is disposable which provides the surgeon with a choice of tip geometries. From a consistently sharp and controlled penetration to a bladeless entry, the surgeon can choose their geometry without changing the entire instrument. A locking shielding mechanism is attached to the main trocar to guard the tip during insertion.

About NeoSurg Technologies

NeoSurg Technologies, Inc., based in Houston, TX, is a privately held medical device company focused on bringing breakthrough products for minimally invasive surgery to market. These products are based on the Company’s patented technology, which allows the combination of disposable components with reusable components in a sophisticated and reliable system.

For more information on NeoSurg Technologies, Inc. visit the company Website at or contact:

Pete O’Heeron

President and Chief Executive Officer

(281) 461-6211

Certain statements made by the Company which are not historical facts may be considered forward-looking statements, including, and without limitation, statements as to trends, management’s beliefs, expectations and opinions, which are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors, which may cause actual results to differ materially from those forward-looking statements.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Pete O'heeron
Visit website